Since the inception of the office of technology ventures and the passage of the Bayh-Dole Act in 1980, OMRF has established a long track record of successful partnerships with industry to support and enhance our investigators’ research efforts. The office of technology ventures works closely with individual investigators to advance their technologies through the research and development pipeline.
The office of technology ventures group focuses on distinct areas. Our department works closely with OMRF’s faculty to identify and develop promising technologies with potential translational applications. Through our strong network of industry contacts, we promote collaborations with biotech and pharmaceutical companies to help fund and advance research in our facilities. Finally, we facilitate technology commercialization through out-licensing and the creation of start-up companies. Discoveries incubated by OMRF’s office of technology ventures have resulted in three FDA-approved drugs, a diagnostic test and numerous start-up companies.
As part of our research support function, we provide legal and administrative assistance for collaborations with industry and academic partners, including the processing and management of material transfer, confidentiality, inter-institutional, sponsored research and licensing agreements.